12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation

NCT00139750 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer